New York, NY
Linked In
You Tube
Columbia University Irving Medical Center
Trials at this location:
HCRN-GU16-243
PhAse I/II StuDy of Modern ImmunotherApy in BCG-RelaPsing UroThelial Carcinoma of the BLADDER – (ADAPT-BLADDER) HCRN GU16-243
Status: Open to Accrual
HCRN-GU20-436
NePtune: A Phase 2 Study of Neoadjuvant PARP Inhibition followed by Radical Prostatectomy in Patients with Unfavorable Intermediate-Risk or High-Risk Prostate Cancer with BRCA1/2 Gene Alterations
Status: Open to Accrual
HCRN-GU22-587
Advanced Renal Cell Cancer Combination ImmunoThErapy Clinical Trial (ARCITECT)
Status: Open to Accrual
HCRN-GU16-260
Phase II study of front line therapy with nivolumab and salvage nivolumab + ipilimumab in patients with advanced renal cell carcinoma
Status: Closed to Accrual
HCRN-MEL17-309
Phase II single-arm multi-center study of adjuvant ipilimumab in combination with nivolumab in subjects with high-risk ocular melanoma
Status: Closed to Accrual
Facebook
Hoosier Cancer Research Network on Facebook
Linked In
You Tube
Twitter